Clinical Trial Update: Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation [Phase 2]

View source ↗

Summary

Phase 2 single-site pilot trial of QLS-111 ophthalmic solution evaluating posterior perfusion and vessel dilation in non-proliferative diabetic retinopathy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy
• Normal Tension Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• QLS-111 Ophthalmic Solution

Snippet

Sponsor: Qlaris Bio, Inc. | Conditions: Non-proliferative Diabetic Retinopathy (NPDR), Open-angle Glaucoma (OAG) | Phase 2 | Status: RECRUITING